Successful treatment with miltefosine of disseminated cutaneous leishmaniasis in a severely immunocompromised patient infected with HIV-1.

C. Schraner,B. Hasse,U. Hasse,D. Baumann,A. Faeh,G. Burg,F. Grimm,A. Mathis,R. Weber,H. Günthard
DOI: https://doi.org/10.1086/430444
IF: 20.999
2005-06-15
Clinical Infectious Diseases
Abstract:We describe here a case of disseminated cutaneous leishmaniasis due to Leishmania major in a severely immunocompromised patient from Burkino Faso, Africa, who is infected with human immunodeficiency virus-1. The skin lesions failed to respond to full treatment courses of amphotericin B, sodium stibogluconate, and liposomal amphotericin B but were successfully treated with miltefosine, an alkylphosphocholine analogue.
What problem does this paper attempt to address?